FDA

FDA needs to act boldly on unproven exosome therapies

exosomes-visualized-by-EM

The FDA needs to do more about clinics and suppliers of unproven “exosome therapies.” Dubious exosomes are sadly just the newest gimmick for some firms in the stem cell/regenerative medicine clinic arena right now. They are available at many stem cell and other clinics right now, but who knows what’s in the syringe? Also, people […]

FDA needs to act boldly on unproven exosome therapies Read More »

In landmark step, judge does not defer to FDA in stem cell clinic chain case, orders full trial

Judge-Jesus-Bernal

In what could be a serious legal warning sign for the stem cell field, California federal district court Judge Jesus Bernal denied the government’s motion for summary judgement against Cell Surgical Network, et al. related to their marketing of an unproven fat stem cell product via their chain of clinics. The FDA is seeking a

In landmark step, judge does not defer to FDA in stem cell clinic chain case, orders full trial Read More »

R3 Stem Cell still raises red flags for me after FDA letter including do one-get one meeting

R3-Stem-Cell-Course

Back in May, the FDA cautioned a stem cell clinic firm called R3 Stem Cell and its leader David Greene about what they were doing. Importantly, the agency indicated that some of R3’s stem cells may be unapproved drug products. FDA and R3 Stem Cell While the FDA didn’t send R3 Stem Cell a formal warning

R3 Stem Cell still raises red flags for me after FDA letter including do one-get one meeting Read More »

Congress pushes FDA on stem cell clinic mess in new letter

Congress-letter-to-FDA-stem-cell-clinics-2019

It can be kind of a big deal when politicians, especially at the federal level, write the FDA about stem cells. Is this going to be good news or bad? Some combination? I tend to worry that some senators or representatives might pressure the FDA to weaken oversight. However, lately it seems like the opposite

Congress pushes FDA on stem cell clinic mess in new letter Read More »

Permanent injunction on clinic firm US Stem Cell is big blow to fat clinics

US-Stem-Cell-Clinic-2

Today the United States District Court of the Southern District of Florida entered a permanent injunction against stem cell clinic firm US Stem Cell and co-defendants including U.S. Stem Cell Clinic. Patients have been harmed by the unproven treatments sold by these firms. US Stem had lost the case a couple weeks back, but now

Permanent injunction on clinic firm US Stem Cell is big blow to fat clinics Read More »

Groundbreaking defeat for US Stem Cell, fat stem cell clinic industry in federal court

us-stem-cell-clinic

In a precedent-setting decision, a federal court has ruled for the FDA against a key stem cell clinic firm called U.S. Stem Cell, Inc. The court granted summary judgment for the FDA in its suit seeking a permanent injunction against the Florida stem cell clinic firm. While the company is likely going to appeal, this is

Groundbreaking defeat for US Stem Cell, fat stem cell clinic industry in federal court Read More »

Dissecting Liveyon FDA inspection report & troubled perinatal stem cell industry

Liveyon

The perinatal stem cell clinic supplier Liveyon has had many issues recently including an FDA inspection that  in my view didn’t go well and which I’ll return to in a minute. First, some background on the company and this troubled industry. E. coli and other pathogens ended up in some of the Liveyon product somehow

Dissecting Liveyon FDA inspection report & troubled perinatal stem cell industry Read More »

FDA needs to quickly act against IRBs enabling risky fat stem cell clinics

alphabet-soup-819x1024-239x3001

Institutional review boards or IRBs are some of the biggest enablers of risky, unproven stem cell clinics. We often see statements on stem cell clinic websites to the effect that they have approvals from IRBs so the clinic firms must think that patients like to see that. Why would specific IRBs approve for-profit “experiments” by

FDA needs to quickly act against IRBs enabling risky fat stem cell clinics Read More »

Clinic biz US Stem (USRM) may be kaput in matter of weeks or months

Joint-motion-for-summary-judgement-1

In a surprising development, the United States government (FDA and DOJ) and the stem cell clinic firm, US Stem Cell (USRM), Inc., that it has sued seeking a permanent injunction, have agreed on something! According to new court records on Pacer (see screenshot), they have both given up on mediation in the federal lawsuit. Further,

Clinic biz US Stem (USRM) may be kaput in matter of weeks or months Read More »

Scott Gottlieb leaving FDA: possible reasons, impact on stem cell field, & more

Dr.-Scott-Gottlieb

Maybe the announcement that Commissioner Scott Gottlieb will be leaving the FDA soon shouldn’t have caught us all off-guard, but it did. Gottlieb isn’t a perfect Commissioner, but he brought a sensible, open approach to running the FDA that was very refreshing. Amongst all the top leadership in the Trump administration, Scott Gottlieb stood out

Scott Gottlieb leaving FDA: possible reasons, impact on stem cell field, & more Read More »

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.